For Patients

Cancer Treatment Updates

Study identifies potential approach to treat severe respiratory distress in patients with COVID-19

June 5th, 2020

As described in an NCI Media Availability, early data from a clinical study suggest that treatment with the cancer drug acalabrutinib provided clinical benefit to a small group of patients with severe COVID-19.

Read More

Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma

May 26th, 2020

In an NCI study, an alternative treatment regimen called dose-adjusted EPOCH-R that is less toxic than standard dose-intensive chemotherapy was highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status.

Read More

Higher daily step count linked with lower all-cause mortality

March 24th, 2020

In a new study, higher daily step counts were associated with lower mortality risk from all causes. Researchers found that the number of steps taken each day, but not the intensity of the stepping, had a strong association with mortality.

Read More

NCI statement on clinical trials during COVID-19 pandemic

March 19th, 2020

Statement from the National Cancer Institute providing information regarding treatment of cancer patients and participation in clinical trials during the COVID-19 pandemic.

Read More

NCI study provides genetic insights into osteosarcoma in children

March 19th, 2020

A new study offers insight into genetic alterations associated with osteosarcoma, the most common bone tumor of children and adolescents, and the findings have implications for genetic testing of children with osteosarcoma and their families.

Read More

In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

March 18th, 2020

An NCI clinical trial finds the drug selumetinib improves outcomes for children with neurofibromatosis type 1 (NF1), shrinking inoperable tumors called plexiform neurofibromas, reducing pain, and improving function and overall quality of life.

Read More

Annual Report to the Nation: Cancer death rates continue to decline

March 12th, 2020

The 2020 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline in the United States for all cancer sites combined. A companion study looked at Healthy People 2020 targets for four common cancers.

Read More

Testing with combined biopsy method improves prostate cancer diagnosis in NCI study

March 4th, 2020

Testing for prostate cancer with a combined biopsy method led to more accurate diagnosis and prediction of the course of the disease in an NCI study. The method is poised to reduce the risk of prostate cancer overtreatment and undertreatment.

Read More

Immunotherapy drug improves outcomes for some children with relapsed leukemia

December 10th, 2019

For children and young adults with certain relapsed B-cell acute lymphoblastic leukemia (B-ALL), the immunotherapy drug blinatumomab is superior to standard chemotherapy, an NCI-sponsored Children’s Oncology Group trial shows.

Read More

Study quantifies impact of NCI-sponsored trials on clinical cancer care

September 18th, 2019

Nearly half of phase 3 cancer clinical trials carried out by the NCI-sponsored SWOG Cancer Research Network were associated with clinical care guidelines or new drug approvals, a study in JAMA Network Open shows.

Read More

 < 1 2 3 4 >  Last ›